Gill S, Tasian SK, Ruella M, et al. Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor–modified T cells. Blood. 2014;123(15):2343-2354.

In the Acknowledgments section on pages 2352-2353 in the 10 April 2014 issue, funding from the Pennsylvania Department of Health is not mentioned. The error has been corrected in the online version, which now differs from the print version.